Loading clinical trials...
Loading clinical trials...
Treatment of Chronic Central Serous Chorioretinopathy With Open-label Anecortave Acetate
Conditions
Interventions
Anecortave Acetate Sterile suspension 15 mg
Anecortave Acetate
Locations
2
United States
Manhattan Eye, ear & Throat Institute
New York, New York, United States
Vitreous-Retina-Macula Consultants of New York,PC
New York, New York, United States
Start Date
May 1, 2007
Primary Completion Date
July 1, 2010
Last Updated
October 25, 2012
Lead Sponsor
Manhattan Eye, Ear & Throat Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions